CRIS Current Research Information System

DE LORENZO, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.540
NA - Nord America 3.319
EU - Europa 2.166
AF - Africa 244
SA - Sud America 133
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.408
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.265
VN - Vietnam 1.022
SG - Singapore 915
CN - Cina 903
IT - Italia 579
GB - Regno Unito 302
SE - Svezia 292
DE - Germania 231
HK - Hong Kong 168
KR - Corea 140
IN - India 129
NL - Olanda 121
FR - Francia 105
IE - Irlanda 102
CI - Costa d'Avorio 94
CH - Svizzera 91
RU - Federazione Russa 88
BR - Brasile 84
BD - Bangladesh 70
FI - Finlandia 68
SC - Seychelles 46
TG - Togo 39
CA - Canada 36
JP - Giappone 31
ZA - Sudafrica 30
AT - Austria 29
JO - Giordania 28
UA - Ucraina 27
BG - Bulgaria 22
NG - Nigeria 21
ID - Indonesia 20
TR - Turchia 20
AR - Argentina 18
BE - Belgio 18
EE - Estonia 18
PH - Filippine 18
GR - Grecia 16
PL - Polonia 16
TW - Taiwan 12
IQ - Iraq 11
PK - Pakistan 11
PS - Palestinian Territory 10
LT - Lituania 8
MX - Messico 8
RO - Romania 8
EC - Ecuador 7
ES - Italia 7
SA - Arabia Saudita 7
CL - Cile 6
TH - Thailandia 6
VE - Venezuela 6
EG - Egitto 5
NI - Nicaragua 5
UZ - Uzbekistan 5
PE - Perù 4
CO - Colombia 3
HR - Croazia 3
LB - Libano 3
MY - Malesia 3
PT - Portogallo 3
PY - Paraguay 3
BO - Bolivia 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CG - Congo 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DK - Danimarca 1
FJ - Figi 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TV - Tuvalu 1
Totale 9.408
Salva come PNG Salva come JPEG
Città #
Singapore 655
Ashburn 333
Hefei 318
Dallas 300
Southend 255
Chandler 238
Hanoi 228
Fairfield 225
Ho Chi Minh City 219
San Jose 201
Dong Ket 162
Hong Kong 153
Woodbridge 128
Houston 125
Seoul 121
Dublin 102
Wilmington 101
Beijing 100
Bologna 95
Abidjan 94
Santa Clara 93
Seattle 93
Boardman 90
Bern 82
Princeton 82
Cambridge 77
Ann Arbor 75
New York 74
Helsinki 62
Council Bluffs 56
Rome 47
Los Angeles 45
Da Nang 44
Frankfurt am Main 42
Lauterbourg 42
Turin 42
Lomé 39
Milan 35
Nanjing 35
Amman 28
Berlin 28
Haiphong 28
Bengaluru 27
Tokyo 25
Buffalo 23
Redondo Beach 23
Westminster 23
Sofia 22
San Diego 21
Redmond 18
Abeokuta 17
London 17
Shanghai 17
Toronto 17
Guangzhou 16
São Paulo 16
Vienna 16
Brussels 15
Chicago 15
Padova 15
Tongling 15
Ravenna 13
Florence 12
Jakarta 12
Munich 12
Warsaw 12
Des Moines 11
Düsseldorf 11
Jinan 11
Orem 11
Redwood City 11
Shenyang 11
Bến Tre 10
Can Tho 10
Changsha 10
Montreal 10
Ninh Bình 10
Amsterdam 9
Biên Hòa 9
Groningen 9
Olalla 9
The Dalles 9
Ankara 8
Bremen 8
Halhul 8
Hải Dương 8
Istanbul 8
Long Xuyen 8
Norwalk 8
Nuremberg 8
Phoenix 8
Saint Petersburg 8
Vũng Tàu 8
Wuhan 8
Falkenstein 7
Forlì 7
Jacksonville 7
Medford 7
San Francisco 7
Torino 7
Totale 6.110
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 461
Adjuvant treatment in biliary tract cancer 345
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES 304
Specific Toxicity of Maintenance Olaparib Versus Placebo in Advanced Malignancies: A Systematic Review and Meta-analysis 303
An astonishing case of liver-only metastatic colorectal cancer cured by FOLFOXIRI alone 284
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis 267
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 260
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients 252
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 243
Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report 234
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 228
Fulminant hepatitis in a patient with hepatocellular carcinoma related to nonalcoholic steatohepatitis treated with sorafenib. 226
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention 215
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis 213
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept 209
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience 208
Second-line treatment in advanced biliary tract cancer: Today and tomorrow 207
How to choose between percutaneous transhepatic and endoscopic biliary drainage in malignant obstructive jaundice: An updated systematic review and meta-analysis 200
Long-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: A case report. 197
Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: A systematic review and meta-analysis 197
In Reply 195
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 193
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma 190
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation. 188
Combination makes strength: a narrative review of transarterial radioembolization plus immune checkpoint inhibitors for hepatocellular carcinoma 187
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 187
Immunotherapy with checkpoint inhibitors for hepatocellular carcinoma: Where are we now? 184
Should patients on levothyroxine therapy be screened for pancreatic cancer? 183
Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial 179
Cholangiocarcinoma: From risk to prevention? 173
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 172
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster 162
Treatment of combined hepatocellular and cholangiocarcinoma 155
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 153
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib 152
Adjuvant Treatment and Follow-up Strategies 149
Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases? 149
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 142
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma 142
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 129
Trend of rifampicin resistant, MDR and XDR tuberculosis in Italy, 2009–2016 125
Regorafenib for the treatment of hepatocellular carcinoma 122
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 119
Non-alcoholic steatohepatitis as a risk factor for intrahepatic cholangiocarcinoma and its prognostic role 116
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma 113
Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical development 103
Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain? 99
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trials 96
Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma 82
null 75
Microbiota, NASH, HCC and the potential role of probiotics 65
null 56
Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab 50
Totale 9.638
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.395
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021199 0 0 0 0 0 0 0 0 0 0 0 199
2021/2022961 112 46 46 64 74 29 30 67 84 61 219 129
2022/20231.180 114 169 56 115 84 77 46 68 207 58 60 126
2023/2024327 34 51 16 28 16 69 13 19 17 26 21 17
2024/20251.496 68 161 145 89 144 53 122 110 49 150 121 284
2025/20264.014 374 432 539 282 319 172 604 102 644 272 125 149
Totale 9.638